References
- Zelefsky M, Moughan J, Owen J, et al. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: the 1999 Patterns of Care survey for prostate cancer. Int J Radiat Oncol Biol Phys 2004;59:1053-1061 https://doi.org/10.1016/j.ijrobp.2003.12.011
- Kuban DA, Thames HD, Levy LB, et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 2003;57:915-928 https://doi.org/10.1016/S0360-3016(03)00632-1
- Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999;353: 267-272 https://doi.org/10.1016/S0140-6736(98)05180-0
- Koper PC. Stromm JC, Putten WL, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 1999;43:727-734 https://doi.org/10.1016/S0360-3016(98)00406-4
- Koper PC, Jansen P, Putten W, et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiot oncol 2004;73:1-9 https://doi.org/10.1016/j.radonc.2004.07.020
- Michalski JM, Winter K, Purdy JA, et al. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys 2003;56:192-198 https://doi.org/10.1016/S0360-3016(03)00072-5
- Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999;85: 2460-2468 https://doi.org/10.1002/(SICI)1097-0142(19990601)85:11<2460::AID-CNCR23>3.0.CO;2-N
- Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:241-249 https://doi.org/10.1016/S0167-8140(99)00100-0
- Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-1116 https://doi.org/10.1016/S0360-3016(02)02857-2
- Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166: 876-881 https://doi.org/10.1016/S0022-5347(05)65855-7
- Zelefsky MJ, Fuks Z, Leibel SA. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002;3: 229-237
- Goldner G, Wachter-Gerstner N, Wachter S, et al. Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report. Strahlenther Onkol 2003;179:320-327 https://doi.org/10.1007/s00066-003-1029-9
- Schultheiss TE, Lee WR, Hunt MA, et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:3-11 https://doi.org/10.1016/S0360-3016(96)00468-3
- Pinkawa M, Asadpour B, Gagel B, et al. Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder. Int J Radiat Oncol Biol Phys 2006;53:856-861
- Pinkawa M, Fischedick K, Branka A, et al. Low-grade toxicity after conformal radiation therapy for prostate cancerimpact of bladder volume. Int J Radiat Oncol Biol Phys 2006; 64:835-841 https://doi.org/10.1016/j.ijrobp.2005.09.003
- Kim TH, Chie EK, Kim DY, et al. Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys 2005;62:769-775 https://doi.org/10.1016/j.ijrobp.2004.11.015
- Pinkawa M, Siluschek J, Gagel B, et al. Postoperative radiotherapy for prostate cancer. Strahlenther Onkol 2007;183: 23-29 https://doi.org/10.1007/s00066-007-1588-2
- Higgins PD, Weaver R, Dusenbery, KE. Evaluation of bladder dose in intensity-modulated radiation therapy of the prostate. Medi Dosim 2006;31:197-200 https://doi.org/10.1016/j.meddos.2005.12.016
- Kupelian PA. Langen KM, Zeidan OA, et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;66: 876-882 https://doi.org/10.1016/j.ijrobp.2006.06.011
- Han Y, Shin EH, Huh SJ, et al. Interfractional dose variation during intensity-modulated radiation therapy for cervical cancer assessed by weekly ct evaluation. Int J Radiat Oncol Biol Phys 2006;65:617-623 https://doi.org/10.1016/j.ijrobp.2006.02.005
- Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:1321-1329 https://doi.org/10.1016/0360-3016(95)00225-1
- The National Cancer Institute Common Terminology Criteria for Adverse Events v3.0 (NCI CTCAE v3.0). Available from: http://ctep.cancer.gov/reporting/ctc.html. Accessed June 10, 2007
- Schnider P, Birner P, Gendo A, Ratheiser K, Auff E. Bladder volume determination: portable 3-D versus stationary 2-d ultrasound device. Arch Phys Med Rehabil 2000;81:18-21 https://doi.org/10.1016/S0003-9993(00)90215-6
- Byun S, Kim HH, Lee E, Paick J, Kamg W, Oh S. Accuracy of bladder volume determinations by ultrasonography: are they accurate over entire bladder volume range? Urology 2003; 62:656-660 https://doi.org/10.1016/S0090-4295(03)00559-4
- Pinkawa M, Asadpour B, Siluschek J, et al. Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder. Radiot Oncol 2007;83:163-167 https://doi.org/10.1016/j.radonc.2007.03.015
- Lebesque JV, Bruce AM, Kroes G, et al. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:1109-1119 https://doi.org/10.1016/0360-3016(95)00253-7
- Stam MR, vanLin EN, Vight LP, et al. Bladder filling variation during radiation treatment of prostate cancer: can the use of a bladder ultrasound scanner and biofeedback optimize bladder filling? Int J Radiat Oncol Biol Phys 2006;65:371-377 https://doi.org/10.1016/j.ijrobp.2005.12.039
- O'Doherty UM, McNair HA, Norman AR, et al. Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiot Oncol 2006;79:335-340 https://doi.org/10.1016/j.radonc.2006.05.007
- Fiorino C, Foppiano F, Franzone P, et al. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiot Oncol 2005;74:187-195 https://doi.org/10.1016/j.radonc.2004.10.002
- Bayley AJ, Catton CN, Haycocks T, et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 2004;70:37-44 https://doi.org/10.1016/j.radonc.2003.08.007
- Antolak JA, Rosen II, Childress CH, Zagars GK, Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 1998;42:661-672 https://doi.org/10.1016/S0360-3016(98)00248-X
- Rowe JW, Shock NW, DeFronzo RA, et al. The influence of age on the renal response to water deprivation in man. Nephron 1976;17:270-278 https://doi.org/10.1159/000180731
- Kirkland, JL, Lye M, Levy DW, Banerjee, AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J 1983;287:1665-1667 https://doi.org/10.1136/bmj.287.6406.1665
- Sugimoto E. Analysis of salt and water intake by continuous determination of blood volume and plasma sodium concentration. Jpn J Physiol 1988;38:519-529 https://doi.org/10.2170/jjphysiol.38.519
- Maughan RJ, Watson P, Evans GH, Broad N, Shirreffs SM. Water balance and salt losses in competitive football. Int J Sport Nutr Exerc Metab 2007;17:583-594 https://doi.org/10.1123/ijsnem.17.6.583
- Yeung CK, Sit FK, To LK, et al. Reduction in nocturnal functional bladder capacity is a common factor in the pathogenesis of refractory nocturnal enuresis. BJU Int 2002;90:302-307 https://doi.org/10.1046/j.1464-410X.2002.02884.x
- Rushton HG, Belman AB, Zaontz MR, Skoog SJ, Sihelnik S. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis. J Urol 1996;156:651-655 https://doi.org/10.1016/S0022-5347(01)65775-6
- Eller DA, Austin PF, Tanguay S, Homsy YL. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis. Eur Urol 1998;3:25-29
- Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-1239 https://doi.org/10.1001/jama.294.10.1233
- Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53:1097-1105 https://doi.org/10.1016/S0360-3016(02)02829-8
- Peeters ST, Heemsbergen WD, Koper PC, et al. Doseresponse in radiotherapy for localized prostate cancer: results of the dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006;24:1990-1996 https://doi.org/10.1200/JCO.2005.05.2530
- Park SW, Oh DH, Bae HS, Cho BC, Park JH, Han SH. Application of Intensity Modulated Radiation Therapy (IMRT) in Prostate Cancer. J Koreans Soc Ther Radiol Oncol 2002;20: 68-72